interleukin-1 receptor antagonist (DuPont)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin-1 receptor antagonist (DuPont)
Drug Alias NameIL-1ra (DuPont)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor antagonistsInterleukins inhibitors
TargetsInterleukin-1 receptorInterleukins
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma Company
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A